Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
jRCTs031220226Completed
Open-label, single-arm trial of [18F]K-40, sponsored by Takeda Science Foundation. Primary endpoint: Primary: Volume of distribution and receptor concentration of [18F]K-40. Started Sep 2022; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on jRCTs031220226.